Kyri K. Van Hoose

Insider Reports History

Location
San Diego, CA
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyri K. Van Hoose:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dermata Therapeutics, Inc. SVP, CFO Common Stock 130,423 $395,181 $3.03 23 Dec 2025 Direct
Dermata Therapeutics, Inc. SVP, CFO Series C Warrant (Right to Buy) 122,549 23 Dec 2025 Direct
Dermata Therapeutics, Inc. SVP, CFO Series D Warrant (Right to Buy) 122,549 23 Dec 2025 Direct
Dermata Therapeutics, Inc. SVP, CFO Stock Option (right to buy) 18,000 02 Jan 2026 Direct
Dermata Therapeutics, Inc. SVP, CFO Warrant (Right to Buy) 7,874 23 Dec 2025 Direct

Insider Reports Filed by Kyri K. Van Hoose

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DRMA Dermata Therapeutics, Inc. 02 Jan 2026 1 $0 4 SVP, CFO 06 Jan 2026, 20:00
DRMA Dermata Therapeutics, Inc. 23 Dec 2025 5 $0 4 SVP, CFO 29 Dec 2025, 19:53
DRMA Dermata Therapeutics, Inc. 21 Jan 2025 2 $0 4 SVP, CFO 23 Jan 2025, 17:03
DRMA Dermata Therapeutics, Inc. 13 Jan 2025 1 $0 4 SVP, CFO 14 Jan 2025, 18:50
DRMA Dermata Therapeutics, Inc. 04 Jan 2024 1 $0 4 SVP, CFO 05 Jan 2024, 21:00
DRMA Dermata Therapeutics, Inc. 03 Jan 2023 1 $0 4 SVP, CFO 05 Jan 2023, 15:06
DRMA Dermata Therapeutics, Inc. 03 Jan 2022 1 $0 4 SVP, Chief Financial Officer 05 Jan 2022, 18:15
DRMA Dermata Therapeutics, Inc. 01 Sep 2021 1 $0 4 Chief Financial Officer 01 Sep 2021, 20:32
DRMA Dermata Therapeutics, Inc. 01 Sep 2021 0 $0 3 Chief Financial Officer 01 Sep 2021, 20:30
/report/000120919121032824-van-hoose-kyri-k-2021-05-14 Turning Point Therapeutics, Inc. 14 May 2021 0 $0 3 Principal Accounting Officer 14 May 2021, 17:24